Small airways test in idiopathic pulmonary fibrosis
Part of Lungs & breathing clinical trials.
This study measures how well the small airways in your lungs work if you have idiopathic pulmonary fibrosis (IPF). It aims to find better ways to assess the disease and could lead to improved care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with IPF (idiopathic pulmonary fibrosis)
- You have not had a sudden worsening of IPF in the past 6 months
- You do not have asthma, COPD, or similar chronic lung diseases
- You are not on long-term bronchodilators or steroid inhalers
- You are not on chronic steroids or immunosuppressant medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people with pulmonary fibrosis can breathe in and aims to see if their breathing flow rate is linked to their condition. It may help doctors understand more about the disease and plan better care.
This study looks at how well your lungs and breathing muscles work during exercise. It aims to help doctors better understand and support people with IPF.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study tests an inhaled medication for people with idiopathic pulmonary fibrosis (IPF), a lung condition that causes scarring. The goal is to see if the drug is safe and how it works in the body. It might help by targeting the lungs directly with fewer side effects.
This study looks at people with a condition called idiopathic pulmonary fibrosis (IPF), which causes lung scarring. Researchers want to develop a tool to predict how the disease will progress, so they will collect health data over time to see what factors affect outcomes.
This study is testing new diagnostic methods for people with COPD, IPF, or combined pulmonary fibrosis and emphysema. It involves collecting blood and saliva samples and using monitoring devices to better understand these conditions.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.